Advertisement

Index by author

November 01, 1986; Volume 30,Issue 5

A

  1. Andersson, T

    1. Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
      T Andersson, C Dahlgren, T Pozzan, O Stendahl and P D Lew
      Molecular Pharmacology November 1986, 30 (5) 437-443;

B

  1. Baker, S P

    1. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
      S P Baker and P Posner
      Molecular Pharmacology November 1986, 30 (5) 411-418;

C

  1. Carlson, K E

    1. Fractionation of the beta subunit common to guanine nucleotide-binding regulatory proteins with the cytoskeleton.
      K E Carlson, M J Woolkalis, M G Newhouse and D R Manning
      Molecular Pharmacology November 1986, 30 (5) 463-468;

  2. Collins, A C

    1. Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
      M J Marks, J A Stitzel, E Romm, J M Wehner and A C Collins
      Molecular Pharmacology November 1986, 30 (5) 427-436;

  3. Curella, P

    1. Induction of tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: effect of the inducing agents alone or in combination on the enzyme levels and rate of synthesis of tyrosine hydroxylase.
      A W Tank, L Ham and P Curella
      Molecular Pharmacology November 1986, 30 (5) 486-496;
    2. Induction of mRNA for tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: evidence for the regulation of tyrosine hydroxylase synthesis by multiple mechanisms in cells exposed to elevated levels of both inducing agents.
      A W Tank, P Curella and L Ham
      Molecular Pharmacology November 1986, 30 (5) 497-503;

D

  1. Dahlgren, C

    1. Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
      T Andersson, C Dahlgren, T Pozzan, O Stendahl and P D Lew
      Molecular Pharmacology November 1986, 30 (5) 437-443;

  2. DeCaprio, A P

    1. Mechanisms of in vitro pyrrole adduct autoxidation in 2,5-hexanedione-treated protein.
      A P DeCaprio
      Molecular Pharmacology November 1986, 30 (5) 452-458;

E

  1. Entman, M L

    1. Evidence for increased membrane permeability of plasmalemmal vesicles from livers of phenobarbital-induced CCl4-intoxicated rats.
      J O Tsokos-Kuhn, C V Smith, J R Mitchell, C A Tate and M L Entman
      Molecular Pharmacology November 1986, 30 (5) 444-451;

F

  1. Feldman, R D

    1. Phenylarsine oxide inhibits agonist-induced changes in photolabeling but not agonist-induced desensitization of the beta-adrenergic receptor.
      R D Feldman, W McArdle and C Lai
      Molecular Pharmacology November 1986, 30 (5) 459-462;

G

  1. Gnegy, M E

    1. Effect of cholera toxin on the activation of adenylate cyclase by calmodulin in bovine striatum.
      C K Mickevicius, J K Harrison and M E Gnegy
      Molecular Pharmacology November 1986, 30 (5) 469-475;

H

  1. Ham, L

    1. Induction of tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: effect of the inducing agents alone or in combination on the enzyme levels and rate of synthesis of tyrosine hydroxylase.
      A W Tank, L Ham and P Curella
      Molecular Pharmacology November 1986, 30 (5) 486-496;
    2. Induction of mRNA for tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: evidence for the regulation of tyrosine hydroxylase synthesis by multiple mechanisms in cells exposed to elevated levels of both inducing agents.
      A W Tank, P Curella and L Ham
      Molecular Pharmacology November 1986, 30 (5) 497-503;

  2. Harrison, J K

    1. Effect of cholera toxin on the activation of adenylate cyclase by calmodulin in bovine striatum.
      C K Mickevicius, J K Harrison and M E Gnegy
      Molecular Pharmacology November 1986, 30 (5) 469-475;

L

  1. Lai, C

    1. Phenylarsine oxide inhibits agonist-induced changes in photolabeling but not agonist-induced desensitization of the beta-adrenergic receptor.
      R D Feldman, W McArdle and C Lai
      Molecular Pharmacology November 1986, 30 (5) 459-462;

  2. Lew, P D

    1. Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
      T Andersson, C Dahlgren, T Pozzan, O Stendahl and P D Lew
      Molecular Pharmacology November 1986, 30 (5) 437-443;

M

  1. Manning, D R

    1. Fractionation of the beta subunit common to guanine nucleotide-binding regulatory proteins with the cytoskeleton.
      K E Carlson, M J Woolkalis, M G Newhouse and D R Manning
      Molecular Pharmacology November 1986, 30 (5) 463-468;

  2. Marks, M J

    1. Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
      M J Marks, J A Stitzel, E Romm, J M Wehner and A C Collins
      Molecular Pharmacology November 1986, 30 (5) 427-436;

  3. McArdle, W

    1. Phenylarsine oxide inhibits agonist-induced changes in photolabeling but not agonist-induced desensitization of the beta-adrenergic receptor.
      R D Feldman, W McArdle and C Lai
      Molecular Pharmacology November 1986, 30 (5) 459-462;

  4. Mickevicius, C K

    1. Effect of cholera toxin on the activation of adenylate cyclase by calmodulin in bovine striatum.
      C K Mickevicius, J K Harrison and M E Gnegy
      Molecular Pharmacology November 1986, 30 (5) 469-475;

  5. Mitchell, J R

    1. Evidence for increased membrane permeability of plasmalemmal vesicles from livers of phenobarbital-induced CCl4-intoxicated rats.
      J O Tsokos-Kuhn, C V Smith, J R Mitchell, C A Tate and M L Entman
      Molecular Pharmacology November 1986, 30 (5) 444-451;

  6. Mosimann, W

    1. Phosphorylation of tyrosine hydroxylase on at least three sites in rat pheochromocytoma PC12 cells treated with 56 mM K+: determination of the sites on tyrosine hydroxylase phosphorylated by cyclic AMP-dependent and calcium/calmodulin-dependent protein kinases.
      E Tachikawa, A W Tank, N Yanagihara, W Mosimann and N Weiner
      Molecular Pharmacology November 1986, 30 (5) 476-485;

N

  1. Newhouse, M G

    1. Fractionation of the beta subunit common to guanine nucleotide-binding regulatory proteins with the cytoskeleton.
      K E Carlson, M J Woolkalis, M G Newhouse and D R Manning
      Molecular Pharmacology November 1986, 30 (5) 463-468;

P

  1. Paul, S M

    1. gamma-Aminobutyric acid (GABA)- and barbiturate-mediated 36Cl- uptake in rat brain synaptoneurosomes: evidence for rapid desensitization of the GABA receptor-coupled chloride ion channel.
      R D Schwartz, P D Suzdak and S M Paul
      Molecular Pharmacology November 1986, 30 (5) 419-426;

  2. Posner, P

    1. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
      S P Baker and P Posner
      Molecular Pharmacology November 1986, 30 (5) 411-418;

  3. Pozzan, T

    1. Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
      T Andersson, C Dahlgren, T Pozzan, O Stendahl and P D Lew
      Molecular Pharmacology November 1986, 30 (5) 437-443;

R

  1. Romm, E

    1. Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
      M J Marks, J A Stitzel, E Romm, J M Wehner and A C Collins
      Molecular Pharmacology November 1986, 30 (5) 427-436;

S

  1. Schwartz, R D

    1. gamma-Aminobutyric acid (GABA)- and barbiturate-mediated 36Cl- uptake in rat brain synaptoneurosomes: evidence for rapid desensitization of the GABA receptor-coupled chloride ion channel.
      R D Schwartz, P D Suzdak and S M Paul
      Molecular Pharmacology November 1986, 30 (5) 419-426;

  2. Smith, C V

    1. Evidence for increased membrane permeability of plasmalemmal vesicles from livers of phenobarbital-induced CCl4-intoxicated rats.
      J O Tsokos-Kuhn, C V Smith, J R Mitchell, C A Tate and M L Entman
      Molecular Pharmacology November 1986, 30 (5) 444-451;

  3. Stendahl, O

    1. Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
      T Andersson, C Dahlgren, T Pozzan, O Stendahl and P D Lew
      Molecular Pharmacology November 1986, 30 (5) 437-443;

  4. Stitzel, J A

    1. Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
      M J Marks, J A Stitzel, E Romm, J M Wehner and A C Collins
      Molecular Pharmacology November 1986, 30 (5) 427-436;

  5. Suzdak, P D

    1. gamma-Aminobutyric acid (GABA)- and barbiturate-mediated 36Cl- uptake in rat brain synaptoneurosomes: evidence for rapid desensitization of the GABA receptor-coupled chloride ion channel.
      R D Schwartz, P D Suzdak and S M Paul
      Molecular Pharmacology November 1986, 30 (5) 419-426;

T

  1. Tachikawa, E

    1. Phosphorylation of tyrosine hydroxylase on at least three sites in rat pheochromocytoma PC12 cells treated with 56 mM K+: determination of the sites on tyrosine hydroxylase phosphorylated by cyclic AMP-dependent and calcium/calmodulin-dependent protein kinases.
      E Tachikawa, A W Tank, N Yanagihara, W Mosimann and N Weiner
      Molecular Pharmacology November 1986, 30 (5) 476-485;

  2. Tank, A W

    1. Phosphorylation of tyrosine hydroxylase on at least three sites in rat pheochromocytoma PC12 cells treated with 56 mM K+: determination of the sites on tyrosine hydroxylase phosphorylated by cyclic AMP-dependent and calcium/calmodulin-dependent protein kinases.
      E Tachikawa, A W Tank, N Yanagihara, W Mosimann and N Weiner
      Molecular Pharmacology November 1986, 30 (5) 476-485;
    2. Induction of tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: effect of the inducing agents alone or in combination on the enzyme levels and rate of synthesis of tyrosine hydroxylase.
      A W Tank, L Ham and P Curella
      Molecular Pharmacology November 1986, 30 (5) 486-496;
    3. Induction of mRNA for tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: evidence for the regulation of tyrosine hydroxylase synthesis by multiple mechanisms in cells exposed to elevated levels of both inducing agents.
      A W Tank, P Curella and L Ham
      Molecular Pharmacology November 1986, 30 (5) 497-503;

  3. Tate, C A

    1. Evidence for increased membrane permeability of plasmalemmal vesicles from livers of phenobarbital-induced CCl4-intoxicated rats.
      J O Tsokos-Kuhn, C V Smith, J R Mitchell, C A Tate and M L Entman
      Molecular Pharmacology November 1986, 30 (5) 444-451;

  4. Tsokos-Kuhn, J O

    1. Evidence for increased membrane permeability of plasmalemmal vesicles from livers of phenobarbital-induced CCl4-intoxicated rats.
      J O Tsokos-Kuhn, C V Smith, J R Mitchell, C A Tate and M L Entman
      Molecular Pharmacology November 1986, 30 (5) 444-451;

W

  1. Wehner, J M

    1. Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
      M J Marks, J A Stitzel, E Romm, J M Wehner and A C Collins
      Molecular Pharmacology November 1986, 30 (5) 427-436;

  2. Weiner, N

    1. Phosphorylation of tyrosine hydroxylase on at least three sites in rat pheochromocytoma PC12 cells treated with 56 mM K+: determination of the sites on tyrosine hydroxylase phosphorylated by cyclic AMP-dependent and calcium/calmodulin-dependent protein kinases.
      E Tachikawa, A W Tank, N Yanagihara, W Mosimann and N Weiner
      Molecular Pharmacology November 1986, 30 (5) 476-485;

  3. Woolkalis, M J

    1. Fractionation of the beta subunit common to guanine nucleotide-binding regulatory proteins with the cytoskeleton.
      K E Carlson, M J Woolkalis, M G Newhouse and D R Manning
      Molecular Pharmacology November 1986, 30 (5) 463-468;

Y

  1. Yanagihara, N

    1. Phosphorylation of tyrosine hydroxylase on at least three sites in rat pheochromocytoma PC12 cells treated with 56 mM K+: determination of the sites on tyrosine hydroxylase phosphorylated by cyclic AMP-dependent and calcium/calmodulin-dependent protein kinases.
      E Tachikawa, A W Tank, N Yanagihara, W Mosimann and N Weiner
      Molecular Pharmacology November 1986, 30 (5) 476-485;
Back to top

In this issue

Advertisement